Brain Waste-Clearance Impairments Tied to ME/CFS

A new perspective article from Stanford researchers proposes that dysfunction of the glymphatic system, the brain’s waste-clearance network, may be a central contributor to the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). The glymphatic system typically removes metabolic byproducts such as lactate, glutamate, tau, and beta-amyloid, especially during deep sleep.

When this system is impaired, these metabolites can accumulate, triggering oxidative stress, neuroinflammation, and impaired neuronal signaling.

The authors outline multiple biological pathways in ME/CFS that may converge on glymphatic failure, including blood–brain barrier disruption, chronic neuroinflammation, mitochondrial dysfunction, impaired cerebral blood flow, sleep instability, dysautonomia, and viral reactivation. They highlight AQP4, a water-channel protein in astrocytes essential for glymphatic flow, as a possible mechanistic link: oxidative stress, autoantibody activity, or membrane disruption may mislocalize or reduce AQP4, compromising waste clearance.

These disruptions may help explain hallmark symptoms such as post-exertional malaise, brain fog, unrefreshing sleep, and orthostatic intolerance.

The paper also discusses emerging therapeutic strategies targeting glymphatic function, including sleep-based interventions, neuromodulation, and agents that modulate AQP4 regulation.

While not a clinical study, the article provides a cohesive model that unifies many ME/CFS abnormalities within a glymphatic-centered framework, offering new directions for diagnostics and future treatment research. The findings add to a growing body of evidence confirming that the cognitive and neurological challenges described by ME/CFS patients are rooted in identifiable biological dysfunction, directly countering the long-held misconception that these symptoms were imagined.

Citation

Nemat-Gorgani, M., Jensen, M. A., & Davis, R. W. (2025). Glymphatic System Dysregulation as a Key Contributor to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. International Journal of Molecular Sciences, 26(23), 11524. https://doi.org/10.3390/ijms262311524